Desmopressin (dDAVP) is a synthetic analogue of arginine vasopressin. The current wholesale price list contains one Price on request entry: 4 mcg/mL / Injectable Solution. The quote must identify the salt form, excipients, pack size, route, regulatory status and batch documents. The cited source is a review of medicinal desmopressin; it does not verify the identity, quality or handling of independently supplied material.
| Identity | Desmopressin (dDAVP) is a synthetic analogue of arginine vasopressin. |
| Exact molecular form | Confirm the peptide sequence, disulfide state, C-terminal form, salt and calculated mass in the current product specification. |
| Observed identity | Reconcile the expected molecular form with the identity method and observed mass reported for the allocated batch. |
| Listed presentation | 4 mcg/mL / Injectable Solution; price is available on request. |
| Solution specification | Confirm concentration basis, salt form, excipients, pH, fill volume, container closure and sterility or endotoxin status as applicable. |
| Handling | Use formulation-specific storage and in-use instructions from the current product and batch documentation. |
Price on request
The current wholesale price list marks this presentation Price on request. The listed minimum order is 100+ total units; confirm pack size, specification and final quote before ordering.
| SKU / form | Price |
|---|---|
| 4 mcg/mL / Injectable Solution | Price on request |
The price list supplies a concentration and dosage form, not a complete medicinal-product specification. The quote and batch documents must close that gap.
Confirm that the quoted material is desmopressin (dDAVP), then obtain the supplier's sequence, molecular-form and batch-identity documentation.
Confirm salt form, concentration basis, excipients, pH, fill volume, container closure, pack count and intended route.
Request the current analytical certificate and the documents appropriate to the intended market and research use. Do not infer approval status from published medicinal-product literature.
Clinical literature is route-, formulation- and population-specific. It does not set the storage, purity or release specification for this listed presentation.
Richardson and Robinson (1985). Drugs Five Years Later: Desmopressin. Annals of Internal Medicine. DOI: 10.7326/0003-4819-103-2-228
Study scope: A review spanning human clinical uses rather than one experimental population. Medicinal desmopressin formulations available in the reviewed period; route and formulation vary.
What it supports: Supports general background on desmopressin as a synthetic analogue of arginine vasopressin and the clinical contexts discussed in the review.
Boundary: The review does not verify this quoted product, a fixed potency multiplier, current formulation details, storage instructions or batch quality.
Desmopressin (dDAVP) is a synthetic analogue of arginine vasopressin. Confirm the molecular form for the quoted material in its batch documentation.
The current wholesale price list contains one entry: 4 mcg/mL / Injectable Solution. Its price is available on request; pack size, salt form and excipients must be confirmed in the quote.
The price list marks this presentation Price on request, so no numeric price or availability state is published.
It supports general background on medicinal desmopressin pharmacology. It does not verify the supplied solution or make all routes and formulations interchangeable.
Confirm concentration basis, salt form, pH, excipients, fill volume, container closure, sterility or endotoxin status as applicable, and current batch results.
Follow the instructions for the quoted formulation and allocated batch. This page does not publish one storage rule or in-use window for every desmopressin product.